Kewaunee Scientific (NASDAQ:KEQU) reported record revenue and outlined continued investments in product development, manufacturing capacity, international expansion and potential acquisitions during its 2026 annual meeting of stockholders.
President and Chief Executive Officer Thomas D. Hull III sa
Companies Reporting Before The Bell • Ollie's Bargain Outlet (NASDAQ:OLLI) is estimated to report quarterly earnings at $0.44 per share on revenue of $468.55 million.
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
Kewanuee Scientific Corp's (NASDAQ: KEQU) Indian subsidiary has secured a $17.3 million contract from Dangote Oil Refinery Company Limited for laboratory...
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
Companies Reporting Before The Bell
• Nanobiotix (NASDAQ:NBTX) is likely to report earnings for its first quarter.
• Waterdrop (NYSE:WDH) is expected to report...
Companies Reporting Before The Bell
• Northern Technologies (NASDAQ:NTIC) is likely to report quarterly earnings at $0.13 per share on revenue of $14.10 million....
